BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price dropped 9.2% during trading on Tuesday . The company traded as low as $0.1930 and last traded at $0.2047. 931,289 shares traded hands during trading, a decline of 99% from the average daily volume of 62,169,492 shares. The stock had previously closed at $0.2255.
BioRestorative Therapies Price Performance
The firm has a market cap of $335.63 million, a price-to-earnings ratio of -0.19 and a beta of 102.36. The firm’s fifty day moving average is $0.35 and its 200-day moving average is $0.40.
About BioRestorative Therapies
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
